A Study of Using Ultrasound to Evaluate Post-Transplant Acute Liver Rejection


About this study

Liver biopsy is routinely performed at day 7 after liver transplant at Mayo to evaluate acute liver rejection.The purpose of this study is to assess the feasibility of a non-invasive evaluation of acute liver rejection by using ultrasound measurements.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients of liver transplant
  • Age greater than 18 and less than 80
  • BMI no greater than 35

Exclusion Criteria: 

  • Lack capacity to consent
  • Unreliable ultrasound measurements

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ivan Nenadic Wood, Ph.D.

Closed for enrollment

Contact information:

Jill Weston

(507) 538-4981


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer